Revolutionary Findings on Atopic Dermatitis Treatment Unveiled at EADV 2026 #United_States #San_Francisco #Atopic_Dermatitis #Nektar_Therapeutics #Rezpegaldesleukin

Revolutionary Findings on Atopic Dermatitis Treatment Unveiled at EADV 2026 #United_States #San_Francisco #Atopic_Dermatitis #Nektar_Therapeutics #Rezpegaldesleukin
Nektar Therapeutics to Unveil Key Findings on Rezpegaldesleukin at EADV Congress 2026 #United_States #San_Francisco #Nektar_Therapeutics #Rezpegaldesleukin #EADV_Congress
Nektar Therapeutics Announces New Employee Stock Options Grants Under Nasdaq Listing Rule 5635(c)(4) #United_States #San_Francisco #NKTR #Nektar_Therapeutics #stock_options